BLACK DIAMOND THERAPEUTICS, INC.
Profile
Company Names
BLACK DIAMOND THERAPEUTICS, INC.
ASET THERAPEUTICS, INC.
Addresses
139 MAIN STREET, CAMBRIDGE, MA 02142
25 HEALTH SCIENCES DRIVE, STONY BROOK, NY 11790
Phone Numbers
617-417-5868
(212) 692-6810
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
2016
State Incorporated:
DELAWARE
Total Amount Raised:
$146,337,620.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2019-11-25
$84,999,941.00
$84,999,941.00
$0.00
Equity
3
2018-12-21
$44,236,469.00
$87,224,867.00
$42,988,398.00
Equity
2
2018-08-11
$5,000,000.00
$10,000,000.00
$5,000,000.00
Equity
1
2017-03-14
$12,101,210.00
$12,101,210.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALI
BEHBAHANI
DIRECTOR
ROTATION MEDICAL INC
| DENALI MEDICAL II, INC.
| MINERVA SURGICAL INC
| PROSPEX MEDICAL III, INC.
| OCULEVE, INC.
| CVRX INC
| IVANTIS, INC.
| ADAPTIMMUNE LTD
| CARDIONOMIC, INC.
| CVRX, INC.
| SOLACE THERAPEUTICS INC
| CRISPR THERAPEUTICS AG
| OYSTER POINT PHARMA, INC.
| GENOCEA BIOSCIENCES, INC.
| BLACK DIAMOND THERAPEUTICS, INC.
| SPYGLASS OPHTHALMICS, INC.
| ARCELLX, INC.
| NKARTA, INC.
| NEA BH SPV, L.P.
| NEA BH SPV II, L.P.
| MONTE ROSA THERAPEUTICS, INC.
| 858 THERAPEUTICS, INC.
| NEW ENTERPRISE ASSOCIATES 18, L.P.
| NEA 18 VENTURE GROWTH EQUITY, L.P.
| FIRSTLIGHT BIO, INC.
| NEXO THERAPEUTICS, INC.
| LAUNCHPAD THERAPEUTICS, INC.
| NEA SH SPV, L.P.
| SPYGLASSPHARMA, INC.
| NEA RP SPV, L.P.
| NEA CH SPV, L.P.
| NEA TS 2024 SPV, L.P.
| NEA SECONDARY OPPORTUNITY FUND, L.P.
| TUNE THERAPEUTICS, INC.
BRADLEY
BOLZON
DIRECTOR
METABOLEX, INC.
| FLEXION THERAPEUTICS INC
| INCEPTION 3, INC.
| INCEPTION 4, INC.
| VERSANT VENTURE CAPITAL V, L.P.
| VERSANT AFFILIATES FUND V, L.P.
| VERSANT OPHTHALMIC AFFILIATES I, L.P.
| VERSANT VENTURE CAPITAL V (CANADA), LP
| INCEPTION 5, INC.
| INCEPTION IBD, INC.
| CRISPR THERAPEUTICS AG
| VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.
| VERSANT VENTURE V AIV, L.P.
| VERSANT VENTURE CAPITAL VI, L.P.
| MISTRAL THERAPEUTICS, INC.
| VERSANT VOYAGEURS I FEEDER, L.P.
| BLACK DIAMOND THERAPEUTICS, INC.
| VERSANT VENTURE CAPITAL VII, L.P.
| NORTHERN MOSAIC LP
| VERSANT VOYAGEURS I, L.P.
| VERSANT VOYAGEURS I PARALLEL, L.P.
| MONTE ROSA THERAPEUTICS, INC.
| VERSANT VANTAGE II, L.P.
| VERSANT VOYAGEURS II, L.P.
| VERSANT VOYAGEURS II (CANADA), L.P.
| VERSANT VENTURE CAPITAL VIII, L.P.
| VERSANT VENTURE CAPITAL VIII (CANADA), L.P.
| VERSANT VOYAGEURS III, L.P.
| VERSANT VOYAGEURS III (CANADA), L.P.
| VERSANT VANTAGE III, L.P.
| VERSANT VANTAGE III (CANADA), L.P.
| VERSANT VENTURE CAPITAL IX, L.P.
| VERSANT VENTURE CAPITAL IX (CANADA), L.P.
| VERSANT VENTURE CAPITAL SPV I (SAB), L.P.
ALEXANDER
MAYWEG
DIRECTOR
GARRY
MENZEL
DIRECTOR
CHRISTOPHER
ROBERTS
EXECUTIVE OFFICER
NEXT STEP MEDIA NETWORK, LLC
| AMCOR LTD
| GLOBAL CRAFT TRADING, INC.
| PROTEIN BAR, INC.
| CHOP-T CREATIVE SALAD CO LLC
| ELEVAR TECHNOLOGIES, INC.
| CHOP-T HOLDINGS, LLC
| QUANTUM COMPUTING INC.
| BLACK DIAMOND THERAPEUTICS, INC.
| GOOD NATURE AGRO, INC.
| FOUNDERS TABLE RESTAURANT GROUP, LLC
| PITBULL TOPCO, LLC
RAJEEV
SHAH
DIRECTOR
CIVITAS THERAPEUTICS, INC.
| KALA PHARMACEUTICALS, INC.
| RA PHARMACEUTICALS, INC.
| SATSUMA PHARMACEUTICALS, INC.
| EIDOS THERAPEUTICS, INC.
| BLACK DIAMOND THERAPEUTICS, INC.
| RA CAPITAL HEALTHCARE FUND LP
| RA CAPITAL HEALTHCARE INTERNATIONAL FUND LTD
| SOLID BIOSCIENCES INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND, L.P.
| RA CAPITAL NEXUS FUND, L.P.
| CELONA, INC.
| RA CAPITAL NEXUS INTERNATIONAL FUND III, L.P.
| RA CAPITAL NEXUS FUND III, L.P.
| ABCURO, INC.
| RA CAPITAL PLANETARY HEALTH FUND, L.P.
| RA CAPITAL PLANETARY HEALTH INTERNATIONAL FUND, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2019-11-25
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
